Concepedia

Publication | Open Access

The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma

DOIFull Paper Access

24

Citations

59

References

2023

Year

Nina Worel, Katharina Grabmeier‐Pfistershammer, Bernhard Kratzer, Martina Schlager, Andreas Tanzmann, Arno Rottal, Ulrike Körmöczi, Edit Porpaczy, Philipp B. Staber, Cathrin Skrabs,
Frontiers in Immunology

Abstract

Low frequency of differentiated CD3<sup>+</sup>CD27<sup>-</sup>CD28<sup>-</sup> T cells at leukapheresis represents a novel pre-infusion blood biomarker predicting a favorable response to CART cell treatment in r/r DLBCL patients.

References

YearCitations

Page 1